CRISTINA RUPP: Open Payments
NPI 1790135721 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 13 payments from 6 companies in 2025. Trend: 2023 $460 · 2024 $285 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $224 |
| GlaxoSmithKline, LLC. | 2 | $109 |
| Lilly USA, LLC | 2 | $33 |
| PFIZER INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: BREZTRI, AREXVY, AIRSUPRA, FARXIGA, MOUNJARO, PAXLOVID, CAPLYTA, Wegovy.
Industry payments across MS — which companies pay providers there.
